Analystreport

Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) had its price target lowered by analysts at UBS Group AG from $24.00 to $23.00. They now have a "buy" rating on the stock.

Teva Pharmaceutical Industries Limited American Depositary Shares  (TEVA) 
Last teva pharmaceutical industries limited american depositary shares earnings: 2/13 04:01 pm Check Earnings Report
US:NYSE Investor Relations: ir.tevapharm.com